Short Term Outcomes From Minimally Invasive Surgery for the Treatment of Atrial Fibrillation

Prospective Analysis of the Wolf Minimaze Procedure for Treatment of Atrial Fibrillation

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00571597

Enrollment

118

Registered

2007-12-12

Start date

2007-03-31

Completion date

2012-05-31

Last updated

2014-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Keywords

surgery, ablation, radiofrequency, minimaze, transtelephonic monitoring

Brief summary

The purpose of this study is to assess the efficacy of minimally invasive surgery for atrial fibrillation.

Detailed description

Patients who are undergoing or who have undergone minimally invasive surgery for atrial fibrillation will be followed prospectively. At 6 to 9 months, 1 and two years post surgery follow-up subjects will receive a trans-telephonic monitor to wear for approximately 1 month, and will submit transmissions on a daily basis. Episodes of atrial fibrillation will be documented during this time. The overall efficacy of the procedure will be assessed based on the freedom from atrial fibrillation at the time of transtelephonic monitoring.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 85 Years

Healthy volunteers

Inclusion criteria

* 18 or older * paroxysmal, persistent, or permanent atrial fibrillation

Exclusion criteria

* concomitant heart surgery requiring open thoracotomy

Design outcomes

Primary

Measure	Time frame
Transtelephonic monitoring for the identification of post surgical Atrial Fibrillation	six months and 1 year

Countries

United States

Outcome results